ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $115,000 | -70.3% | 77,906 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $387,000 | -19.0% | 77,906 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $478,000 | -4.2% | 77,906 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $499,000 | +177.2% | 77,906 | 0.0% | 0.00% | +200.0% |
| Q4 2015 | $180,000 | -52.4% | 77,906 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $378,000 | -12.1% | 77,906 | +24.0% | 0.00% | 0.0% |
| Q2 2015 | $430,000 | -23.2% | 62,844 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $560,000 | +61.4% | 62,844 | +81.1% | 0.00% | +50.0% |
| Q4 2014 | $347,000 | -0.6% | 34,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $349,000 | +25.1% | 34,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $279,000 | -19.6% | 34,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $347,000 | – | 34,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $4,808,000 | 16.67% |
| Pharmstandard International S.A. | 5,120,604 | $1,859,000 | 6.44% |
| SANDERS MORRIS HARRIS LLC | 141,212 | $52,000 | 0.02% |
| ELEMENT CAPITAL MANAGEMENT LLC | 82,808 | $30,000 | 0.01% |
| WEDBUSH SECURITIES INC | 89,500 | $32,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $73,000 | 0.00% |
| LMR Partners LLP | 45,017 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 129,046 | $46,000 | 0.00% |
| STATE STREET CORP | 11,900 | $4,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 193,294 | $70,000 | 0.00% |